SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-21-114019
Filing Date
2021-09-09
Accepted
2021-09-09 07:33:50
Documents
2
Group Members
MICHAEL DERBY

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2127202d1_sc13da.htm SC 13D/A 48291
2 EXHIBIT 1 tm2127202d1_ex99-1.htm EX-99.1 4227
  Complete submission text file 0001104659-21-114019.txt   54234
Mailing Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920 914-205-3481
Timber Pharmaceuticals, Inc. (Subject) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87755 | Film No.: 211243521
SIC: 2834 Pharmaceutical Preparations

Mailing Address 303 SOUTH BROADWAY SUITE 125 TARRYTOWN NY 10591
Business Address 303 SOUTH BROADWAY SUITE 125 TARRYTOWN NY 10591 201-645-4767
TardiMed Sciences LLC (Filed by) CIK: 0001800690 (see all company filings)

IRS No.: 452297650 | State of Incorp.: CT | Fiscal Year End: 1231
Type: SC 13D/A